642 filings
3
Ibrahim B. Dagher
22 Apr 24
BRAINSTORM CELL THERAPEUTICS / Ibrahim B. Dagher ownership change
8:06pm
4
Lebovits Chaim
19 Apr 24
BRAINSTORM CELL THERAPEUTICS / Chaim Lebovits ownership change
6:05am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
11 Apr 24
Other Events
6:10am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
9 Apr 24
BrainStorm Cell Therapeutics Announces Agreement with FDA on a
6:05am
424B5
BCLI
Brainstorm Cell Therapeutics, Inc.
2 Apr 24
Prospectus supplement for primary offering
4:20pm
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
2 Apr 24
Entry into a Material Definitive Agreement
4:15pm
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
1 Apr 24
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
8:15am
4
BCLI
Brainstorm Cell Therapeutics, Inc.
13 Mar 24
BRAINSTORM CELL THERAPEUTICS / Stacy Lindborg ownership change
8:57pm
4
Yablonka Uri
13 Mar 24
BRAINSTORM CELL THERAPEUTICS / Uri Yablonka ownership change
8:56pm
4
BCLI
Brainstorm Cell Therapeutics, Inc.
13 Mar 24
BRAINSTORM CELL THERAPEUTICS / Alla Patlis ownership change
8:55pm
4
Lebovits Chaim
13 Mar 24
BRAINSTORM CELL THERAPEUTICS / Chaim Lebovits ownership change
8:54pm
SC 13G/A
BCLI
Brainstorm Cell Therapeutics, Inc.
12 Feb 24
BRAINSTORM CELL THERAPEUTICS / Ness Kevin Dean ownership change
10:06am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
20 Dec 23
BrainStorm Issues 2023 Letter to Shareholders
5:04pm
DEFA14A
BCLI
Brainstorm Cell Therapeutics, Inc.
22 Nov 23
Additional proxy soliciting materials
4:00pm
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
22 Nov 23
BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS
6:03am
10-Q
2023 Q3
BCLI
Brainstorm Cell Therapeutics, Inc.
Quarterly report
14 Nov 23
12:00am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
14 Nov 23
BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
12:00am
8-K
BCLI
Brainstorm Cell Therapeutics, Inc.
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm